NEW YORK, Dec. 21, 2018 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP announces that class action lawsuits have
commenced on behalf of shareholders of the following publicly-traded companies. Shareholders interested in serving as lead
plaintiff have until the deadlines listed to petition the court and further details about the cases can be found at the links
provided. There is no cost or obligation to you.
PPDAI Group Inc. (NYSE: PPDF)
Class Period: Purchasers of American Depositary Shares pursuant and/or traceable to the Registration Statement issued in
connection with PPDAI's November 2017 Initial Public Offering
Lead Plaintiff Deadline: January 25, 2019
Join the action: https://www.zlk.com/pslra-1/ppdai-group-inc-ppdf-loss-form?wire=3
The complaint alleges that the Registration Statement issued in connection with the IPO contained materially false and/or
misleading statements and/or failed to disclose material information, including that: (1) PPDAI was engaged in predatory lending
practices that saddled subprime borrowers and those with poor or limited credit histories with high interest rate debt they could
not repay; (2) many of PPDAI’s customers were using PPDAI-provided loans to repay existing loans they otherwise could not afford to
repay, thereby inflating PPDAI’s revenues and active borrower numbers and increasing the likelihood of defaults; (3) PPDAI was
experiencing increasing delinquency rates, negatively affecting PPDAI’s reserves; (4) PPDAI’s purported “rapid growth” in the
number and amount of loans had materially dropped off; and (5) PPDAI was providing online loans to college students despite a
government ban on the practice.
To learn more about the PPDAI Group Inc. class action contact jlevi@levikorsinsky.com.
Teladoc Health, Inc. (NYSE: TDOC)
Class Period: March 3, 2016 - December 5, 2018
Lead Plaintiff Deadline: February 11, 2019
Join the action: https://www.zlk.com/pslra-1/teladoc-health-inc-loss-form?wire=3
The lawsuit alleges: Teladoc Health, Inc. made materially false and/or misleading statements throughout the class period and/or
failed to disclose that: (i) Executive Vice President and Chief Operating Officer Mark Hirschhorn was engaged in an inappropriate
sexual relationship with a subordinate; (ii) Hirschhorn and this subordinate engaged in insider trading to provide themselves with
undue benefits; (iii) Hirschhorn caused the subordinate to receive promotions for which she was unqualified, thereby negatively
impacting the Company’s operations; (iv) the Company’s enforcement of its own purported employment and trading policies were
inadequate to prevent the foregoing conduct; and (v) as a result, the Company’s public statements were materially false and
misleading at all relevant times.
To learn more about the Teladoc Health, Inc. class action contact jlevi@levikorsinsky.com.
You have until the lead plaintiff deadlines to request the court appoint you as lead plaintiff. Your ability to share in any
recovery doesn’t require that you serve as a lead plaintiff.
Levi & Korsinsky is a national firm with offices in New York, California, Connecticut, and Washington D.C. The firm’s attorneys
have extensive expertise and experience representing investors in securities litigation and have recovered hundreds of millions of
dollars for aggrieved shareholders. Attorney advertising. Prior results do not guarantee similar outcomes.
CONTACT:
Levi & Korsinsky, LLP
Joseph E. Levi, Esq.
55 Broadway, 10th Floor
New York, NY 10006
jlevi@levikorsinsky.com
Tel: (212) 363-7500
Toll Free: (877) 363-5972
Fax: (212) 363-7171
www.zlk.com
